619 related articles for article (PubMed ID: 18217145)
21. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.
Okawa T; Naomoto Y; Nobuhisa T; Takaoka M; Motoki T; Shirakawa Y; Yamatsuji T; Inoue H; Ouchida M; Gunduz M; Nakajima M; Tanaka N
Clin Cancer Res; 2005 Nov; 11(22):7995-8005. PubMed ID: 16299228
[TBL] [Abstract][Full Text] [Related]
22. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
[TBL] [Abstract][Full Text] [Related]
23. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
24. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
Sato N; Kokame K; Miyata T; Kato H
Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
[TBL] [Abstract][Full Text] [Related]
26. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
27. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
[TBL] [Abstract][Full Text] [Related]
28. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
[TBL] [Abstract][Full Text] [Related]
29. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
[TBL] [Abstract][Full Text] [Related]
30. Involvement of heparanase in vaginal and cesarean section deliveries.
Nadir Y; Kenig Y; Drugan A; Zcharia E; Brenner B
Thromb Res; 2010 Dec; 126(6):e444-50. PubMed ID: 20932554
[TBL] [Abstract][Full Text] [Related]
31. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
32. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells.
Zhao Y; Zhou S; Heng CK
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.
Chen G; Wang D; Vikramadithyan R; Yagyu H; Saxena U; Pillarisetti S; Goldberg IJ
Biochemistry; 2004 May; 43(17):4971-7. PubMed ID: 15109255
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Wu J; Stevenson MJ; Brown JM; Grunz EA; Strawn TL; Fay WP
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):698-704. PubMed ID: 18276908
[TBL] [Abstract][Full Text] [Related]
35. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function.
Lin Z; Kumar A; SenBanerjee S; Staniszewski K; Parmar K; Vaughan DE; Gimbrone MA; Balasubramanian V; García-Cardeña G; Jain MK
Circ Res; 2005 Mar; 96(5):e48-57. PubMed ID: 15718498
[TBL] [Abstract][Full Text] [Related]
36. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
37. An assay to evaluate heparanase procoagulant activity.
Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
[TBL] [Abstract][Full Text] [Related]
38. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
39. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
Zhang JJ; Kelm RJ; Biswas P; Kashgarian M; Madri JA
J Cell Physiol; 2007 Feb; 210(2):527-37. PubMed ID: 17111362
[TBL] [Abstract][Full Text] [Related]
40. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
